Abstract
There are typically three phases identified as contributing to the total testing process. The preanalytical phase starts with the clinician and the patient, when laboratory testing is being considered. This phase also includes decisions about which tests to order (or not), patient identification, blood collection, blood transport, sample processing, and storage to name a few. There are many potential failures that may occur in this preanalytical phase, and these are the topic of another chapter in this book. The second phase, the analytical phase, represents the performance of the test, which is essentially covered in various protocols in this book and the previous edition. The third is the post-analytical phase, which is what occurs after sample testing, and is the topic of the current chapter. Post-analytical issues are generally related to reporting and interpretation of test results. This chapter provides a brief description of these events, as well as guidance for preventing or minimizing post-analytical issues. In particular, there are several strategies for improved post-analytical reporting of hemostasis assays, with this providing the final opportunity to prevent serious clinical errors in patient diagnosis or management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- aCL:
-
Anticardiolipin antibody (assay)
- APCR:
-
Activated protein C resistance
- aPL:
-
Antiphospholipid antibody
- APS:
-
Antiphospholipid (antibody) syndrome
- APTT:
-
Activated partial thromboplastin time
- AT:
-
Antithrombin
- dRVVT:
-
Dilute Russell viper venom time
- FVL:
-
Factor V Leiden
- KCT:
-
Kaolin clotting time
- LA:
-
Lupus anticoagulant
- PC:
-
Protein C
- PS:
-
Protein S
- VKA:
-
Vitamin K antagonist
- VWD:
-
Von Willebrand disease
- VWF:
-
Von Willebrand factor
References
Gosselin RC (2023) Preanalytical variables in hemostasis testing. In: Favaloro EJ, Gosselin RC (eds) Hemostasis and thrombosis: methods and protocols. Methods in molecular biology. Springer, New York, pp 39–50. https://doi.org/10.1007/978-1-0716-3175-1_2
Lippi G, Favaloro EJ (2017) Preanalytical issues in hemostasis and thrombosis testing. Methods Mol Biol 1646:29–42. https://doi.org/10.1007/978-1-4939-7196-1_2
Favaloro EJ, Lippi G, Adcock DM (2008) Preanalytical and postanalytical variables: the leading causes of diagnostic error in haemostasis? Semin Thromb Hemost 34:612–634. https://doi.org/10.1055/s-0028-1104540
Favaloro EJ, Funk (Adcock) DM, Lippi G (2012) Preanalytical variables in coagulation testing associated to diagnostic errors in hemostasis. Lab Med 43:54–60
Adcock DM, Favaloro EJ, Lippi G (2016) Critical pre-examination variables in the hemostasis laboratory and their quality indicators. Clin Biochem 49:1315–1320. https://doi.org/10.1016/j.clinbiochem.2016.08.022
Lippi G, Guidi GC (2007) Risk management in the preanalytical phase of laboratory testing. Clin Chem Lab Med 45:720–727. https://doi.org/10.1515/CCLM.2007.167
Gosselin RC, Marlar RA (2019) Preanalytical variables in coagulation testing: setting the stage for accurate results. Semin Thromb Hemost 45(5):433–448. https://doi.org/10.1055/s-0039-1692700
Favaloro EJ, Mohammed S, Vong R et al (2022) Harmonizing factor assay-related testing performed in a large laboratory network. Blood Coagul Fibrinolysis 33(7):402–411. https://doi.org/10.1097/MBC.0000000000001155
Favaloro EJ, Dean E, Arunachalam S (2022) Evaluating performance of contemporary and historical von Willebrand Factor (VWF) assays in the laboratory identification of von Willebrand Disease (VWD): the Australasian experience. Semin Thromb Hemost 48(6):711–731. https://doi.org/10.1055/s-0042-1753528
Favaloro EJ, Mohammed S, Vong R et al (2022) Harmonizing platelet function analyzer testing and reporting in a large laboratory network. Int J Lab Hematol 44(5):934–944. https://doi.org/10.1111/ijlh.13907
Favaloro EJ, Mohammed S, Vong R et al (2022) A multi-laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network. Int J Lab Hematol 44(3):654–665. https://doi.org/10.1111/ijlh.13818
Favaloro EJ, Dean E, Arunachalam S, Vong R, Mohammed S (2022) Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays. Pathology 54(3):308–317. https://doi.org/10.1016/j.pathol.2021.07.001
Favaloro EJ, Mohammed S, Vong R et al (2021) Verification of the ACL Top 50 family (350, 550 and 750) for harmonization of routine coagulation assays in a large network of 60 laboratories. Am J Clin Pathol 156(4):661–678. https://doi.org/10.1093/ajcp/aqab004
Favaloro EJ, Mohammed S, Vong R et al (2021) A multi-laboratory assessment of congenital thrombophilia assays performed on the ACL Top 50 family for harmonisation of thrombophilia testing in a large laboratory network. Clin Chem Lab Med 59(10):1709–1718. https://doi.org/10.1515/cclm-2021-0499
Favaloro EJ, Gosselin RC, Pasalic L, Lippi G (2023) Hemostasis and thrombosis: an overview focusing on associated laboratory testing to diagnose and help manage related disorders. In: Favaloro EJ, Gosselin RC (eds) Hemostasis and thrombosis: methods and protocols. Methods in molecular biology. Springer, New York, pp 3–38. https://doi.org/10.1007/978-1-0716-3175-1_1
Lippi G (2019) The irreplaceable value of laboratory diagnostics: four recent tests that have revolutionized clinical practice. EJIFCC 30(1):7–13
Devreese KMJ, de Groot PG, de Laat B et al (2020) Guidance from the scientific and standardization committee for lupus anticoagulant/antiphospholipid antibodies of the international society on thrombosis and haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost 18(11):2828–2839. https://doi.org/10.1111/jth.15047
Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, de Groot PG (2009) Official communication of the scientific and standardization committee on lupus anticoagulant/phospholipid-dependent antibodies: update of the guidelines for lupus anticoagulant detection. J Thromb Hemost 7:1737–1740. https://doi.org/10.1111/j.1538-7836.2009.03555.x
Devreese KMJ (2022) Solid phase assays for antiphospholipid antibodies. Semin Thromb Hemost. 48(6):661-671. https://doi.org/10.1055/s-0042-1744364
Devreese KMJ, Ortel TL, Pengo V, de Laat B, Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies (2018) Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. J Thromb Haemost 16(4):809–813. https://doi.org/10.1111/jth.13976
Sadler JE, Budde U, Eikenboom JCJ et al (2006) Update on the pathophysiology and classification of von Willebrand disease: a report of the subcommittee on von Willebrand factor. J Thromb Haemostas 4:2103–2114. https://doi.org/10.1111/j.1538-7836.2006.02146.x
James PD, Connell NT, Ameer B et al (2021) ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv 5(1):280–300. https://doi.org/10.1182/bloodadvances.2020003265
Favaloro EJ, Bonar RA, Mohammed S et al (2016) Type 2M von Willebrand disease – more often misidentified than correctly identified. Haemophilia 22:e145–e155. https://doi.org/10.1111/hae.12903
Favaloro EJ, Bonar RA, Meiring M, Duncan E, Mohammed S, Sioufi J, Marsden K (2014) Evaluating errors in the laboratory identification of von Willebrand disease in the real world. Thromb Res 134:393–403. https://doi.org/10.1016/j.thromres.2014.05.020
Colonne CK, Reardon B, Curnow J, Favaloro EJ (2021) Why is misdiagnosis of von Willebrand disease still prevalent and how can we overcome it? A focus on clinical considerations and recommendations. J Blood Med 12:755–768. https://doi.org/10.2147/JBM.S266791
Cooper PC, Pavlova A, Moore GW, Hickey KP, Marlar RA (2020) Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH. J Thromb Haemost 18(2):271–277. https://doi.org/10.1111/jth.14667
Marlar RA, Gausman JN, Tsuda H, Rollins-Raval MA, Brinkman HJM (2021) Recommendations for clinical laboratory testing for protein S deficiency: communication from the SSC committee plasma coagulation inhibitors of the ISTH. J Thromb Haemost 19(1):68–74. https://doi.org/10.1111/jth.15109
Marlar RA (2023) Laboratory evaluation of thrombophilia. In: Favaloro EJ, Gosselin RC (eds) Hemostasis and thrombosis: methods and protocols. Methods in molecular biology. Springer, New York, pp 177–201. https://doi.org/10.1007/978-1-0716-3175-1_10
Favaloro EJ, Lippi G (2015) Laboratory testing in the era of direct or non-vitamin k antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors. Semin Thromb Hemost 41:208–227. https://doi.org/10.1055/s-0035-1546827
Favaloro EJ, Lippi G (2017) Interference of direct oral anticoagulants (DOACs) in hemostasis assays: high potential for diagnostic false positives and false negatives. Blood Transfus 15(6):491–494. https://doi.org/10.2450/2017.0301-16
Favaloro EJ, McDonald D, Lippi G (2009) Laboratory investigation of thrombophilia: the good, the bad and the ugly. Semin Thromb Hemost 35:695–710. https://doi.org/10.1055/s-0029-1242723
Thachil J, Favaloro EJ, Lippi G (2022) D-dimers-“Normal” levels versus elevated levels due to a range of conditions, including “D-dimeritis,” inflammation, thromboembolism, disseminated intravascular coagulation, and COVID-19. Semin Thromb Hemost. In press. https://doi.org/10.1055/s-0042-1748193
Lippi G, Mullier F, Favaloro EJ (2022) D-dimer: old dogmas, new (COVID-19) tricks. Clin Chem Lab Med 61(5):841–850. https://doi.org/10.1515/cclm-2022-0633
Lippi G, Franchini M, Targher G, Favaloro EJ (2008) Help me, doctor! My D-dimer is raised. Ann Med 40:594–605. https://doi.org/10.1080/07853890802161015
Plebani M (2004) What information on quality specifications should be communicated to clinicians, and how? Clin Chim Acta 346:25–35
Plebani M (2009) Interpretative commenting: a tool for improving the laboratory-clinical interface. Clin Chim Acta 404:46–51. https://doi.org/10.1016/j.cccn.2004.03.019
Favaloro EJ, Lippi G (2010) Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis? Clin Chem Lab Med 48:309–321. https://doi.org/10.1515/CCLM.2010.061
Favaloro EJ, Mohammed S, Lippi G (2018) Postanalytical considerations that may improve the diagnosis or exclusion of haemophilia and von Willebrand disease. Haemophilia 24(6):849–861. https://doi.org/10.1111/hae.13587
Favaloro EJ, Lippi G (2017) Post-analytical issues in hemostasis and thrombosis testing. Methods Mol Biol 1646:545–559. https://doi.org/10.1007/978-1-4939-7196-1_40
Lippi G, Tripodi A, Simundic AM, Favaloro EJ (2015) International survey on d-dimer test reporting: a call for standardization. Semin Thromb Hemost 41:287–293. https://doi.org/10.1055/s-0035-1549092
Longstaff C, Adcock D, Olson JD et al (2016) Harmonisation of D-dimer – a call for action. Thromb Res 137:219–220. https://doi.org/10.1016/j.thromres.2015.11.031
Favaloro EJ, Thachil J (2020) Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation. Clin Chem Lab Med 58(8):1191–1199. https://doi.org/10.1515/cclm-2020-0573
Lippi G, Mattiuzzi C (2016) Critical laboratory values communication: summary recommendations from available guidelines. Ann Transl Med 4(20):400. https://doi.org/10.21037/atm.2016.09.36
Gosselin RC, Adcock D, Dorgalaleh A, Favaloro EJ, Lippi G, Pego JM, Regan I, Siguret V (2020) International council for standardization in haematology recommendations for hemostasis critical values, tests, and reporting. Semin Thromb Hemost 46(4):398–409. https://doi.org/10.1055/s-0039-1697677
Lippi G, Ferrari A, Bovo C, Bassi A (2020) Results of a hospital survey on critical values communication. Diagnosis (Berl) 8(2):275–278. https://doi.org/10.1515/dx-2019-0094
Lippi G, Mattiuzzi C (2016) Critical laboratory values communication: summary recommendations from available guidelines. Ann Transl Med 4:400. https://doi.org/10.21037/atm.2016.09.36
Wang Z, Peng C, Kang H, Fan X, Mu R, Zhou L, He M, Qu B (2019) Design and evaluation of a LIS-based autoverification system for coagulation assays in a core clinical laboratory. BMC Med Inform Decis Mak 3 19(1):123. https://doi.org/10.1186/s12911-019-0848-2
Lippi G, Favaloro EJ (2016) Reflections on the next generation of hemostasis instrumentation. A glimpse into the future? J Lab Med Laboratoriums Medizin 12:2015. https://doi.org/10.1515/labmed-2015-0087
Lippi G, Plebani M, Favaloro EJ (2015) The changing face of hemostasis testing in modern laboratories: consolidation, automation, and beyond. Semin Thromb Hemost 41:294–299. https://doi.org/10.1055/s-0035-1544196
Van Cott EM, Smock KJ, Lippi G (2019) Innovations in thrombosis and hemostasis: a glimpse towards the future of diagnostic analyzers. Semin Thromb Hemost 45(3):225–227. https://doi.org/10.1055/s-0039-1683844
Favaloro EJ, Lippi G (2019) Recent advances in mainstream hemostasis diagnostics and coagulation testing. Semin Thromb Hemost 45(3):228–246. https://doi.org/10.1055/s-0038-1676579
Emani SM (2019) Novel coagulation analyzers in development: a glimpse toward the future of microfluidics. Semin Thromb Hemost 45(3):302–307. https://doi.org/10.1055/s-0039-1683843
Favaloro EJ, Pasalic L (2022) Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants. Res Pract Thromb Haemost 6(2):e12676. https://doi.org/10.1002/rth2.12676. PMID: 35316943
Gosselin RC, Honeychurch K, Kang HJ, Dwyre DM (2020) Effect of multiple freeze-thaw cycles on coagulation testing. Semin Thromb Hemost 46(4):515–520. https://doi.org/10.1055/s-0040-1709474
Jacoby RC, Owings JT, Holmes J, Battistella FD, Gosselin RC, Paglieroni TG (2001) Platelet activation and function after trauma. J Trauma 51(4):639–647. https://doi.org/10.1097/00005373-200110000-00003
Conflicts of Interest
RCG receives consulting fees from Sysmex America Inc. All other authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Favaloro, E.J., Gosselin, R.C., Pasalic, L., Lippi, G. (2023). Post-analytical Issues in Hemostasis and Thrombosis Testing: An Update. In: Favaloro, E.J., Gosselin, R.C. (eds) Hemostasis and Thrombosis. Methods in Molecular Biology, vol 2663. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3175-1_53
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3175-1_53
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3174-4
Online ISBN: 978-1-0716-3175-1
eBook Packages: Springer Protocols